JP2021525541A5 - - Google Patents

Info

Publication number
JP2021525541A5
JP2021525541A5 JP2020567958A JP2020567958A JP2021525541A5 JP 2021525541 A5 JP2021525541 A5 JP 2021525541A5 JP 2020567958 A JP2020567958 A JP 2020567958A JP 2020567958 A JP2020567958 A JP 2020567958A JP 2021525541 A5 JP2021525541 A5 JP 2021525541A5
Authority
JP
Japan
Prior art keywords
domain sequence
seq
positions
mutant cpf1
cpf1 endonuclease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020567958A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021525541A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/064444 external-priority patent/WO2019233990A1/en
Publication of JP2021525541A publication Critical patent/JP2021525541A/ja
Publication of JP2021525541A5 publication Critical patent/JP2021525541A5/ja
Priority to JP2024226441A priority Critical patent/JP2025075025A/ja
Pending legal-status Critical Current

Links

JP2020567958A 2018-06-04 2019-06-04 変異体Cpf1エンドヌクレアーゼ Pending JP2021525541A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024226441A JP2025075025A (ja) 2018-06-04 2024-12-23 変異体Cpf1エンドヌクレアーゼ

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP18175707 2018-06-04
EP18175707.1 2018-06-04
EP18190950 2018-08-27
EP18190950.8 2018-08-27
PCT/EP2019/064444 WO2019233990A1 (en) 2018-06-04 2019-06-04 Mutant cpf1 endonucleases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024226441A Division JP2025075025A (ja) 2018-06-04 2024-12-23 変異体Cpf1エンドヌクレアーゼ

Publications (2)

Publication Number Publication Date
JP2021525541A JP2021525541A (ja) 2021-09-27
JP2021525541A5 true JP2021525541A5 (cg-RX-API-DMAC7.html) 2022-07-05

Family

ID=66676556

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020567958A Pending JP2021525541A (ja) 2018-06-04 2019-06-04 変異体Cpf1エンドヌクレアーゼ
JP2024226441A Pending JP2025075025A (ja) 2018-06-04 2024-12-23 変異体Cpf1エンドヌクレアーゼ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024226441A Pending JP2025075025A (ja) 2018-06-04 2024-12-23 変異体Cpf1エンドヌクレアーゼ

Country Status (12)

Country Link
US (2) US12152257B2 (cg-RX-API-DMAC7.html)
EP (1) EP3802806A1 (cg-RX-API-DMAC7.html)
JP (2) JP2021525541A (cg-RX-API-DMAC7.html)
KR (1) KR20210028163A (cg-RX-API-DMAC7.html)
CN (1) CN112424349A (cg-RX-API-DMAC7.html)
AU (1) AU2019282094A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020024736A2 (cg-RX-API-DMAC7.html)
CA (1) CA3102676A1 (cg-RX-API-DMAC7.html)
IL (1) IL279153A (cg-RX-API-DMAC7.html)
MA (1) MA52739A (cg-RX-API-DMAC7.html)
MX (1) MX2020013229A (cg-RX-API-DMAC7.html)
WO (1) WO2019233990A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
EP3652312A1 (en) 2017-07-14 2020-05-20 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
AU2019291918B2 (en) 2018-06-29 2025-06-12 Editas Medicine, Inc. Synthetic guide molecules, compositions and methods relating thereto
CN111521781B (zh) * 2020-02-24 2021-07-30 广州医科大学附属第一医院(广州呼吸中心) 一种用于新冠肺炎病毒SARS-CoV-2核酸的检测试剂盒及其检测方法
CN116848241A (zh) * 2020-12-17 2023-10-03 孟山都技术公司 工程化无ssDNA酶的CRISPR核酸内切酶
US20240110163A1 (en) 2021-01-29 2024-04-04 Wageningen Universiteit Crispr-associated based-editing of the complementary strand
EP4441209A4 (en) * 2021-11-29 2025-12-17 Editas Medicine Inc MANIPULATED CRISPR/Cas12A EFFECT PROTEINS AND USES THEM
EP4486879A1 (en) 2022-03-01 2025-01-08 Wageningen Universiteit Cas12a nickases
EP4499819A1 (en) 2022-03-30 2025-02-05 Basf Agricultural Solutions Seed Us Llc Optimized base editors
WO2024105633A1 (en) 2022-11-18 2024-05-23 Kyoto Prefectural Public University Corporation Compositions for mitophagy induction and uses thereof
EP4638470A1 (en) 2022-12-21 2025-10-29 BASF Agricultural Solutions US LLC Increased editing efficiency by co-delivery of rnp with nucleic acid
AU2024309386A1 (en) 2023-06-30 2025-12-18 Christiana Care Gene Editing Institute, Inc. Nras gene knockout for treatment of cancer
WO2025213016A2 (en) 2024-04-04 2025-10-09 Christiana Care Gene Editing Institute, Inc. Crispr/cas gene editing of neh4 and/or neh5 domains in nrf2
WO2025226816A1 (en) 2024-04-23 2025-10-30 Christiana Care Gene Editing Institute, Inc. Methods of identifying and correlating crispr-induced exon skipping to phenotypic outcomes
CN119506249B (zh) * 2024-11-29 2025-11-07 大连理工大学 一种多PAM选择的基因编辑系统NovaCas-1及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10648020B2 (en) 2015-06-18 2020-05-12 The Broad Institute, Inc. CRISPR enzymes and systems
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
WO2017064546A1 (en) * 2015-09-24 2017-04-20 Crispr Therapeutics Ag Novel family of rna-programmable endonucleases and their uses in genome editing and other applications
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
WO2017106657A1 (en) 2015-12-18 2017-06-22 The Broad Institute Inc. Novel crispr enzymes and systems
KR20260004568A (ko) 2016-04-19 2026-01-08 더 브로드 인스티튜트, 인코퍼레이티드 신규한 crispr 효소 및 시스템
EP3445853A1 (en) 2016-04-19 2019-02-27 The Broad Institute, Inc. Cpf1 complexes with reduced indel activity
CN106244591A (zh) * 2016-08-23 2016-12-21 苏州吉玛基因股份有限公司 修饰crRNA在CRISPR/Cpf1基因编辑系统中的应用
AU2017302551B2 (en) 2016-07-26 2023-04-27 The General Hospital Corporation Variants of CRISPR from Prevotella and Francisella 1 (Cpf1)
WO2018027078A1 (en) * 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
KR20240007715A (ko) 2016-10-14 2024-01-16 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
WO2018074979A1 (en) 2016-10-17 2018-04-26 Nanyang Technological University Truncated crispr-cas proteins for dna targeting
IL306092A (en) 2017-03-23 2023-11-01 Harvard College Nucleic base editors that include nucleic acid programmable DNA binding proteins
EP3612204A4 (en) 2017-04-21 2021-01-27 The General Hospital Corporation INDUCTIBLE, TUNING AND MULTIPLEX HUMAN GENE REGULATION USING CRISPR-CPF1
WO2018195545A2 (en) 2017-04-21 2018-10-25 The General Hospital Corporation Variants of cpf1 (cas12a) with altered pam specificity
US11834665B2 (en) 2017-05-10 2023-12-05 Regents Of The University Of Minnesota Programmable transcription factors and methods
KR102678809B1 (ko) 2017-05-18 2024-06-26 더 브로드 인스티튜트, 인코퍼레이티드 표적화된 핵산 편집을 위한 시스템, 방법 및 조성물
EP3625342B1 (en) 2017-05-18 2022-08-24 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
KR102655021B1 (ko) 2017-07-11 2024-04-04 시그마-알드리치 컴퍼니., 엘엘씨 표적된 게놈 변형을 개선하기 위한 뉴클레오솜 상호작용 단백질 도메인 사용
EP3658573A1 (en) 2017-07-28 2020-06-03 President and Fellows of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
WO2019051097A1 (en) 2017-09-08 2019-03-14 The Regents Of The University Of California RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USING SAME
WO2019075197A1 (en) 2017-10-11 2019-04-18 The General Hospital Corporation METHODS OF DETECTION OF INDIVIDUAL SITE-SPECIFIC PARASITE GENOMIC DEAMINATION BY BASE EDITING TECHNOLOGIES
WO2019126762A2 (en) 2017-12-22 2019-06-27 The Broad Institute, Inc. Cas12a systems, methods, and compositions for targeted rna base editing
CN111788232A (zh) 2018-02-23 2020-10-16 上海科技大学 用于碱基编辑的融合蛋白
EP3660152A4 (en) 2018-03-26 2020-07-15 National University Corporation Kobe University METHOD FOR MODIFYING A TARGET SITE IN DOUBLE-STRANDED DNA IN A CELL
AU2019255789B2 (en) 2018-04-19 2025-11-20 The Regents Of The University Of California Compositions and methods for gene editing

Similar Documents

Publication Publication Date Title
CN110139927B (zh) Crispr-cas9抑制剂
JP2022522650A5 (cg-RX-API-DMAC7.html)
Zimmer et al. Genome and proteome of Listeria monocytogenes phage PSA: an unusual case for programmed+ 1 translational frameshifting in structural protein synthesis
Loessner et al. Evidence for a holin-like protein gene fully embedded out of frame in the endolysin gene of Staphylococcus aureus bacteriophage 187
US20230159927A1 (en) Chromatin remodelers to enhance targeted gene activation
Nambu et al. Peptidoglycan-hydrolyzing activity of the FlgJ protein, essential for flagellar rod formation in Salmonella typhimurium
FI3585910T3 (fi) Koostumukset ja menetelmät proteiinin tuotannon lisäämiseksi bacillus licheniformiksessa
JP2017018125A5 (cg-RX-API-DMAC7.html)
WO2008035205A2 (en) Recombinase polymerase amplification
Fortier et al. Expression and site-directed mutagenesis of the lactococcal abortive phage infection protein AbiK
US20230235306A1 (en) Argonaute protein from eukaryotes and application thereof
KR20210028163A (ko) 돌연변이 cpf1 엔도뉴클레아제
JP2021088567A5 (cg-RX-API-DMAC7.html)
JP2008515450A5 (cg-RX-API-DMAC7.html)
Zago et al. Characterization of the genome of the dairy Lactobacillus helveticus bacteriophage ΦAQ113
US20250270528A1 (en) Crispr polypeptides
Han et al. Hfq globally binds and destabilizes sRNAs and mRNAs in Yersinia pestis
Piazzolla et al. Expression of phage P4 integrase is regulated negatively by both Int and Vis
JP2020127419A5 (cg-RX-API-DMAC7.html)
Sut et al. Protein and DNA effectors control the TraI conjugative helicase of plasmid R1
CN115786305A (zh) 一种紧凑型编辑工具EbCas12a在基因编辑中的应用
China et al. A transcript cleavage factor of Mycobacterium tuberculosis important for its survival
EP2857506A2 (en) Sequence-specific engineered ribonuclease H and the method for determining the sequence preference of DNA-RNA hybrid binding proteins
CN119752847A (zh) 一种可编程TnpB核酸酶基因编辑中的应用
CN104694560A (zh) 一种源于里氏木霉的二硫键异构酶基因Trpdi2及其用途